Cargando…

Impact of the SARS-CoV-2 nucleocapsid 203K/204R mutations on the inflammatory immune response in COVID-19 severity

BACKGROUND: The excessive inflammatory responses provoked by SARS-CoV-2 infection are critical factors affecting the severity and mortality of COVID-19. Previous work found that two adjacent co-occurring mutations R203K and G204R (KR) on the nucleocapsid (N) protein correlate with increased disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Shuaib, Muhammad, Adroub, Sabir, Mourier, Tobias, Mfarrej, Sara, Zhang, Huoming, Esau, Luke, Alsomali, Afrah, Alofi, Fadwa S, Ahmad, Adeel Nazir, Shamsan, Abbas, Khogeer, Asim, Hashem, Anwar M., Almontashiri, Naif A. M., Hala, Sharif, Pain, Arnab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360309/
https://www.ncbi.nlm.nih.gov/pubmed/37475040
http://dx.doi.org/10.1186/s13073-023-01208-0
_version_ 1785076076248039424
author Shuaib, Muhammad
Adroub, Sabir
Mourier, Tobias
Mfarrej, Sara
Zhang, Huoming
Esau, Luke
Alsomali, Afrah
Alofi, Fadwa S
Ahmad, Adeel Nazir
Shamsan, Abbas
Khogeer, Asim
Hashem, Anwar M.
Almontashiri, Naif A. M.
Hala, Sharif
Pain, Arnab
author_facet Shuaib, Muhammad
Adroub, Sabir
Mourier, Tobias
Mfarrej, Sara
Zhang, Huoming
Esau, Luke
Alsomali, Afrah
Alofi, Fadwa S
Ahmad, Adeel Nazir
Shamsan, Abbas
Khogeer, Asim
Hashem, Anwar M.
Almontashiri, Naif A. M.
Hala, Sharif
Pain, Arnab
author_sort Shuaib, Muhammad
collection PubMed
description BACKGROUND: The excessive inflammatory responses provoked by SARS-CoV-2 infection are critical factors affecting the severity and mortality of COVID-19. Previous work found that two adjacent co-occurring mutations R203K and G204R (KR) on the nucleocapsid (N) protein correlate with increased disease severity in COVID-19 patients. However, links with the host immune response remain unclear. METHODS: Here, we grouped nasopharyngeal swab samples of COVID-19 patients into two cohorts based on the presence and absence of SARS-CoV-2 nucleocapsid KR mutations. We performed nasopharyngeal transcriptome analysis of age, gender, and ethnicity-matched COVID-19 patients infected with either SARS-CoV-2 with KR mutations in the N protein (KR patients n = 39) or with the wild-type N protein (RG patients n = 39) and compared to healthy controls (n = 34). The impact of KR mutation on immune response was further characterized experimentally by transcriptomic and proteomic profiling of virus-like-particle (VLP) incubated cells. RESULTS: We observed markedly elevated expression of proinflammatory cytokines, chemokines, and interferon-stimulated (ISGs) genes in the KR patients compared to RG patients. Using nasopharyngeal transcriptome data, we found significantly higher levels of neutrophils and neutrophil-to-lymphocyte (NLR) ratio in KR patients than in the RG patients. Furthermore, transcriptomic and proteomic profiling of VLP incubated cells confirmed a similar hyper-inflammatory response mediated by the KR variant. CONCLUSIONS: Our data demonstrate an unforeseen connection between nucleocapsid KR mutations and augmented inflammatory immune response in severe COVID-19 patients. These findings provide insights into how mutations in SARS-CoV-2 modulate host immune output and pathogenesis and may contribute to more efficient therapeutics and vaccine development. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13073-023-01208-0.
format Online
Article
Text
id pubmed-10360309
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103603092023-07-22 Impact of the SARS-CoV-2 nucleocapsid 203K/204R mutations on the inflammatory immune response in COVID-19 severity Shuaib, Muhammad Adroub, Sabir Mourier, Tobias Mfarrej, Sara Zhang, Huoming Esau, Luke Alsomali, Afrah Alofi, Fadwa S Ahmad, Adeel Nazir Shamsan, Abbas Khogeer, Asim Hashem, Anwar M. Almontashiri, Naif A. M. Hala, Sharif Pain, Arnab Genome Med Research BACKGROUND: The excessive inflammatory responses provoked by SARS-CoV-2 infection are critical factors affecting the severity and mortality of COVID-19. Previous work found that two adjacent co-occurring mutations R203K and G204R (KR) on the nucleocapsid (N) protein correlate with increased disease severity in COVID-19 patients. However, links with the host immune response remain unclear. METHODS: Here, we grouped nasopharyngeal swab samples of COVID-19 patients into two cohorts based on the presence and absence of SARS-CoV-2 nucleocapsid KR mutations. We performed nasopharyngeal transcriptome analysis of age, gender, and ethnicity-matched COVID-19 patients infected with either SARS-CoV-2 with KR mutations in the N protein (KR patients n = 39) or with the wild-type N protein (RG patients n = 39) and compared to healthy controls (n = 34). The impact of KR mutation on immune response was further characterized experimentally by transcriptomic and proteomic profiling of virus-like-particle (VLP) incubated cells. RESULTS: We observed markedly elevated expression of proinflammatory cytokines, chemokines, and interferon-stimulated (ISGs) genes in the KR patients compared to RG patients. Using nasopharyngeal transcriptome data, we found significantly higher levels of neutrophils and neutrophil-to-lymphocyte (NLR) ratio in KR patients than in the RG patients. Furthermore, transcriptomic and proteomic profiling of VLP incubated cells confirmed a similar hyper-inflammatory response mediated by the KR variant. CONCLUSIONS: Our data demonstrate an unforeseen connection between nucleocapsid KR mutations and augmented inflammatory immune response in severe COVID-19 patients. These findings provide insights into how mutations in SARS-CoV-2 modulate host immune output and pathogenesis and may contribute to more efficient therapeutics and vaccine development. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13073-023-01208-0. BioMed Central 2023-07-21 /pmc/articles/PMC10360309/ /pubmed/37475040 http://dx.doi.org/10.1186/s13073-023-01208-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Shuaib, Muhammad
Adroub, Sabir
Mourier, Tobias
Mfarrej, Sara
Zhang, Huoming
Esau, Luke
Alsomali, Afrah
Alofi, Fadwa S
Ahmad, Adeel Nazir
Shamsan, Abbas
Khogeer, Asim
Hashem, Anwar M.
Almontashiri, Naif A. M.
Hala, Sharif
Pain, Arnab
Impact of the SARS-CoV-2 nucleocapsid 203K/204R mutations on the inflammatory immune response in COVID-19 severity
title Impact of the SARS-CoV-2 nucleocapsid 203K/204R mutations on the inflammatory immune response in COVID-19 severity
title_full Impact of the SARS-CoV-2 nucleocapsid 203K/204R mutations on the inflammatory immune response in COVID-19 severity
title_fullStr Impact of the SARS-CoV-2 nucleocapsid 203K/204R mutations on the inflammatory immune response in COVID-19 severity
title_full_unstemmed Impact of the SARS-CoV-2 nucleocapsid 203K/204R mutations on the inflammatory immune response in COVID-19 severity
title_short Impact of the SARS-CoV-2 nucleocapsid 203K/204R mutations on the inflammatory immune response in COVID-19 severity
title_sort impact of the sars-cov-2 nucleocapsid 203k/204r mutations on the inflammatory immune response in covid-19 severity
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360309/
https://www.ncbi.nlm.nih.gov/pubmed/37475040
http://dx.doi.org/10.1186/s13073-023-01208-0
work_keys_str_mv AT shuaibmuhammad impactofthesarscov2nucleocapsid203k204rmutationsontheinflammatoryimmuneresponseincovid19severity
AT adroubsabir impactofthesarscov2nucleocapsid203k204rmutationsontheinflammatoryimmuneresponseincovid19severity
AT mouriertobias impactofthesarscov2nucleocapsid203k204rmutationsontheinflammatoryimmuneresponseincovid19severity
AT mfarrejsara impactofthesarscov2nucleocapsid203k204rmutationsontheinflammatoryimmuneresponseincovid19severity
AT zhanghuoming impactofthesarscov2nucleocapsid203k204rmutationsontheinflammatoryimmuneresponseincovid19severity
AT esauluke impactofthesarscov2nucleocapsid203k204rmutationsontheinflammatoryimmuneresponseincovid19severity
AT alsomaliafrah impactofthesarscov2nucleocapsid203k204rmutationsontheinflammatoryimmuneresponseincovid19severity
AT alofifadwas impactofthesarscov2nucleocapsid203k204rmutationsontheinflammatoryimmuneresponseincovid19severity
AT ahmadadeelnazir impactofthesarscov2nucleocapsid203k204rmutationsontheinflammatoryimmuneresponseincovid19severity
AT shamsanabbas impactofthesarscov2nucleocapsid203k204rmutationsontheinflammatoryimmuneresponseincovid19severity
AT khogeerasim impactofthesarscov2nucleocapsid203k204rmutationsontheinflammatoryimmuneresponseincovid19severity
AT hashemanwarm impactofthesarscov2nucleocapsid203k204rmutationsontheinflammatoryimmuneresponseincovid19severity
AT almontashirinaifam impactofthesarscov2nucleocapsid203k204rmutationsontheinflammatoryimmuneresponseincovid19severity
AT halasharif impactofthesarscov2nucleocapsid203k204rmutationsontheinflammatoryimmuneresponseincovid19severity
AT painarnab impactofthesarscov2nucleocapsid203k204rmutationsontheinflammatoryimmuneresponseincovid19severity